Ñý¼§Ö±²¥

Personal Summary

Dr. Jane Reynolds (she/her) is an Assistant Professor and Co-Director of the VOICES Lab in the School of Speech, Language, Hearing, & Occupational Sciences at Ñý¼§Ö±²¥. She has been a medical Speech-Language Pathologist since 2015 working in hospital inpatient and outpatient settings, and community and university clinics. Dr. Reynolds specializes in the assessment and treatment of voice, swallowing, and upper airway disorders and practices as an SLP at Rocky Mountain Ear, Nose, and Throat where she also provides clinical supervision to graduate Ñý¼§Ö±²¥ from the UM SLHOS program. She conducts research related to behavioral cough suppression therapy, an evidnece-based and highly efficacious treatment for refractory chronic cough. As a professor she is passionate about infusing her clinical expertise into the classroom environment and providing hands-on learning opportunities for Ñý¼§Ö±²¥ to hone their critical thinking skills. Dr. Reynolds and her husband Dr. Daniel Salois of Counselor Education at UM are expecting their first child in December 2024 and enjoy spending time outdoors with their mini aussiedoodle, Pazu.

Education

All degrees received from Ñý¼§Ö±²¥, Missoula, MT

• Ph.D. Speech, Language & Hearing Sciences (December 2022)
• M.S. Communicative Sciences and Disorders (May 2015)
• B.A. Communicative Sciences and Disorders (May 2013)
• B.A. Spanish (May 2013)

Courses Taught

SLP 530 Voice & Resonance Disoders

SLP 640 Swallowing Disorders

CSD 331 Neuroanatomy & Physiology

CSD 330 Anatomy & Physiology 

Teaching Experience

SLP 530 Voice & Resonance Disoders

SLP 640 Swallowing Disorders

CSD 331 Neuroanatomy & Physiology

CSD 330 Anatomy & Physiology 

Research Interests

My research goals reflect my long-term commitment to improving quality-of-life for patients living with refractory chronic cough by 1) working to improve access to behavioral cough suppression therapy (e.g., improve understanding of mechanisms behind cough hypersensitivity syndrome and understand and address barriers to access such as lack of trained SLPs in rural areas) and 2) leveraging technology to enhance the efficacy of behavioral cough suppression therapy (e.g., through online and app-based delivery, and wearable cough frequency monitoring). 

Projects

Grant Funded Research

National Institute of General Medical Sciences (NIGMS, P20GM130418)

2023 CPHR Pilot Project, Center for Population Health Research Ñý¼§Ö±²¥

Reynolds (PI)

06/07/2023-02/28/2024

And continuation award: 3/1/2024-2/28/2025

Internet-Behavioral Cough Suppression Therapy: A Pilot Study

Publications

Slovarp, L. Jette, M., Reynolds, J., Gillespie, A., Barkmeier-Kraemer, J., Sandage, M. Smith, J., Haines, J., Vertigan, A., Mazzone, S. (2024). Misconceptions on Behavioral Cough Suppression Therapy for Pediatric Nonspecific Cough: A Response to Weinberger and Buettner’s Commentary on Fujiki et al. Pediatric Pulmonology.

Wright, M., Slovarp, L., Reynolds, J., Roy, N., Sundar, K., Barkmeier-Kraemer, J. Prevalence of anxiety as a variable in treatment outcomes for individuals with chronic refractory cough. (in press). American Journal of Speech-Language Pathology.

Slovarp, L., Reynolds, J., Tolbert, S., Campbell, S., Welby, S., & Morkrid, P. (2023). Cough Desensitization Treatment for Patients with Refractory Chronic Cough: Results of a Second Pilot Randomized Control Trial. BMC Pulmonary Medicine, 23(1), https://doi.org/10.1186/s12890-023-02423-6

Sundholm, N., Shelly, S., Wright, M., Reynolds, J., Slovarp, L., & Gillespie, A. (2022). Effect of behavioral cough suppression therapy delivered via telehealth. Journal of Voice, S0892-1997(22), https://doi.org/ 10.1016/j.jvoice.2022.11.015

Reynolds, J., Jetté, M., Wright, M., Sundar, K., Gillespie, A., Barkmeier-Kraemer, J., & Slovarp, L. (2022). Normative values for the Leicester Cough Questionnaire on healthy individuals.  Annals of Otology, Rhinology, & Otolaryngology, 132(6), 705-708. https://doi.org/10.1177/00034894221112517

Slovarp, L., Reynolds, J., Bozarth-Dailey, E., Popp, S., Campbell, S., & Morkrid, P. (2022). Cough Desensitization Treatment: a randomized, sham-controlled pilot trial for patients with refractory chronic cough. Respiratory Medicine, 193, 106739. https://doi.org/10.1016/j.rmed.2022.106739

Slovarp, L., Jetté, M., Gillespie, A., Reynolds, J., & Barkmeier-Kraemer, J. (2021). Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy. Lung, 199(3), 263-271. https://doi.org/10.1007/s00408-021-00442-w

Affiliations

Professional Memberships

• American Speech-Language-Hearing Association (2013-Present)
• ASHA Special Interest Group 03 Voice and Upper Airway Disorders (2019-Present)
• Montana Speech-Language-Hearing Association (2010-Present)
• National Center for Faculty Development and Diversity (2022-Present

Specialized Skills

Endoscopic evaluation of voice, swallowing, and upper airway disorders:

-Videostroboscopy

-Continuous laryngoscopy with exercise challenge

- Fiberoptic endoscopic evaluation of swallowing

Professional Experience

Positions held in the School of Speech-Language Hearing & Occupational Sciences at Ñý¼§Ö±²¥.

• Assistant Professor (2022-Present)
• Co-director VOICES Lab (2022-Present)
• Adjunct Professor (2018-2022)
• Doctoral Research Assistant (2018-2022)

Positions held as a Speech-Language Pathologist:

• Rocky Mountain Ear, Nose, & Throat, Missoula MT (2021-present)
• Community Medical Center, Missoula, MT (2018-2022)
• Kalispell Regional Medical Center, Kalispell, MT (2015-2018)
• Whitefish Sports and Rehabilitation, Whitefish, MT (2016-2018)